Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-9 of 9
Keywords: mitogen-activated protein kinase (MAPK)
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Susan Yung, Claudia Y.C. Ng, Kin Yi Au, Kwok Fan Cheung, Qing Zhang, Chenzhu Zhang, Desmond Y.H. Yap, Mel K.M. Chau, Tak Mao Chan
Journal:
Clinical Science
Clin Sci (Lond) (2017) 131 (1): 49–67.
Published: 09 December 2016
... protein-1 (MCP-1) in patients. Binding of anti-dsDNA Abs to HK-2 cells was investigated by cellular ELISA, flow cytometry and immunohistochemistry. IL-6, IL-8 and MCP-1 secretion, mitogen-activated protein kinase (MAPK) activation and the effect of mycophenolic acid (MPA) were investigated by ELISAs...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2010) 118 (3): 221–230.
Published: 01 February 2010
... overload. atherosclerosis mitogen-activated protein kinase (MAPK) reactive oxygen species (ROS) resistin smooth muscle cell signal transducer and activator of transcription (STAT) stretch Correspondence: Professor Kou-Gi Shyu (email [email protected] ). 17 3 2009 16 6 2009...
Includes: Supplementary data
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2010) 118 (5): 315–332.
Published: 23 November 2009
...-Commercial Licence ( http://creativecommons.org/licenses/by-nc/2.5/ ) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. cancer inflammation insulin insulin-like growth factor-1 (IGF-1) mitogen-activated protein...
Articles
Mikiko Shimizu, Michael Tropak, Roberto J. Diaz, Fumiaki Suto, Harinee Surendra, Elena Kuzmin, Jing Li, Gil Gross, Gregory J. Wilson, John Callahan, Andrew N. Redington
Journal:
Clinical Science
Clin Sci (Lond) (2009) 117 (5): 191–200.
Published: 03 August 2009
... consent was obtained. 9 10 2008 16 1 2009 28 1 2009 28 1 2009 © The Authors Journal compilation © 2009 Biochemical Society 2009 limb ischaemia myocardium mitogen-activated protein kinase (MAPK) opioid protein kinase C (PKC) remote ischaemic preconditioning...
Articles
Lucas Fernández-Campo, María T. Grande, Julia Diego, Isabel Fuentes-Calvo, Juan F. Macías-Núñez, Angel Sánchez-Rodríguez, Jesús Grande, Luis García-Ortiz, José M. López-Novoa, Carlos Martínez-Salgado
Journal:
Clinical Science
Clin Sci (Lond) (2009) 116 (2): 165–173.
Published: 15 December 2008
.... Correspondence: Dr Carlos Martínez-Salgado (email [email protected] ). 9 4 2008 5 6 2008 30 6 2008 30 6 2008 © The Authors Journal compilation © 2009 Biochemical Society 2009 Akt antihypertensive medication diabetes hypertension mitogen-activated protein kinase (MAPK) Ras...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2008) 115 (7): 203–218.
Published: 03 September 2008
... hypertrophy intracellular signalling mitogen-activated protein kinase (MAPK) myocardial infarction remodelling An important study in 1995 showed that cardiac-specific overexpression of an activated form of H-Ras (Harvey-Ras) in transgenic mice leads to cardiac hypertrophy and diastolic dysfunction...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2008) 114 (1): 73–83.
Published: 30 November 2007
..., essentially as described by Borbath et al. [ 26 ]. Correspondence: Dr Peter Stärkel ( [email protected] ). 2 5 2007 5 7 2007 3 8 2007 3 8 2007 cell cycle S -farnesylthiosalicylic acid (FTS) hepatocellular carcinoma liver mitogen-activated protein kinase...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2005) 108 (6): 493–495.
Published: 24 May 2005
... partaker in endothelial dysfunction and atherosclerosis [ 2 ]. atherosclerosis C-reactive protein (CRP) interleukin-8 mitogen-activated protein kinase (MAPK) 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitor statin The Biochemical Society 2005 15 3 2005 22 3 2005...
Articles
Chiharu ITO, Hisashi YAMAMOTO, Yusuke FURUKAWA, Shin-ichi TAKEDA, Tetsu AKIMOTO, Osamu IIMURA, Yasuhiro ANDO, Yasushi ASANO, Eiji KUSANO
Journal:
Clinical Science
Clin Sci (Lond) (2004) 107 (1): 81–87.
Published: 23 June 2004
...) forskolin mitogen-activated protein kinase (MAPK) mesangial cell Raf-1 MC (mesangial cell) proliferation is one of the characteristics of progressive glomerular disease. MC proliferation is affected by many factors, including growth factors. One of these, PDGF (platelet-derived growth factor...
